Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.

他のバージョン（1件）を表示する

BACKGROUND: Contemporary screening for prostate cancer frequently identifies small volume, low-grade lesions. Some clinicians have advocated focal prostatic ablation as an alternative to more aggressive interventions to manage these lesions. To identify which patients might benefit from focal ablati...

書誌詳細
主要な著者:	Catto, J, Robinson, M, Albertsen, P, Goepel, JR, Abbod, M, Linkens, D, Davis, M, Rosario, D, Warren, A, Varma, M, Griffiths, D, Grigor, K, Mayer, N, Oxley, J, Deshmukh, N, Lane, J, Metcalfe, C, Donovan, J, Neal, D, Hamdy, F
フォーマット:	Journal article
言語:	English
出版事項:	2011

類似資料

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study
著者:: Catto, J, 等
出版事項: (2011)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
著者:: Rosario, D, 等
出版事項: (2008)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
著者:: Lane, J, 等
出版事項: (2004)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
著者:: Hamdy, FC, 等
出版事項: (2020)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
著者:: Collin, S, 等
出版事項: (2009)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
著者:: Burton, A, 等
出版事項: (2013)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
著者:: Hamdy, F, 等
出版事項: (2006)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
著者:: Freddie C Hamdy, 等
出版事項: (2020-08-01)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
著者:: Zuccolo, L, 等
出版事項: (2013)

Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study
著者:: Dimitropoulou, P, 等
出版事項: (2011)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study.
著者:: Dimitropoulou, P, 等
出版事項: (2011)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
著者:: Rosario, D, 等
出版事項: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
著者:: Rosario, D, 等
出版事項: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
著者:: Rosario, D, 等
出版事項: (2012)

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
著者:: Wade, J, 等
出版事項: (2015)

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
著者:: Neal, D, 等
出版事項: (2019)

A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
著者:: Mills, N, 等
出版事項: (2006)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
著者:: J. Donovan, 等
出版事項: (2003-01-01)

The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression
著者:: Young, GJ, 等
出版事項: (2020)

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
著者:: Mills, N, 等
出版事項: (2003)

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).
著者:: Murad, A, 等
出版事項: (2011)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
著者:: Lane, J, 等
出版事項: (2010)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
著者:: S. Sanghera, 等
出版事項: (2020-10-01)

Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression.
著者:: Catto, J, 等
出版事項: (2006)

Predictive modeling in cancer: where systems biology meets the stock market.
著者:: Abbod, M, 等
出版事項: (2009)

Comparative study of intelligent models for the prediction of bladder cancer progression.
著者:: Abbod, M, 等
出版事項: (2006)

Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial
著者:: Johnston, T, 等
出版事項: (2016)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
著者:: Avery, K, 等
出版事項: (2007)

Artificial intelligence for the prediction bladder cancer
著者:: Abbod, M, 等
出版事項: (2004)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
著者:: Burton, A, 等
出版事項: (2011)

Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
著者:: Catto, J, 等
出版事項: (2009)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
著者:: Donovan, J, 等
出版事項: (2003)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
著者:: Lane, J, 等
出版事項: (2009)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
著者:: Lane, J, 等
出版事項: (2007)

Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial
著者:: Chris Metcalfe, 等
出版事項: (2020-09-01)

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
著者:: Lane, A, 等
出版事項: (2016)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
著者:: Catto, J, 等
出版事項: (2007)

Post-diagnosis serum insulin-like growth factors in relation to dietary and lifestyle changes in the Prostate testing for cancer and Treatment (ProtecT) trial.
著者:: Er, V, 等
出版事項: (2017)

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
著者:: Catto, J, 等
出版事項: (2003)

Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
著者:: Avery, K, 等
出版事項: (2008)